CEA-ROCHE(R) EIA

FDA Premarket Approval P840027 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceCEA-ROCHE(R) EIA
Generic NameSystem, Test, Carcinoembryonic Antigen
ApplicantROCHE DIAGNOSTICS GMBH
Date Received1988-10-27
Decision Date1988-11-29
PMAP840027
SupplementS004
Product CodeDHX 
Advisory CommitteeImmunology
Supplement TypeNormal 180 Day Track
Supplement ReasonOther Report
Expedited ReviewNo
Combination Product No
Applicant Address ROCHE DIAGNOSTICS GMBH 1080 U.s. Hwy. 202 branchburg Township somerville, NJ 08876-3771

Supplemental Filings

Supplement NumberDateSupplement Type
P840027Original Filing
S006 1989-04-11 Normal 180 Day Track
S005 1989-04-11 Normal 180 Day Track
S004 1988-10-27 Normal 180 Day Track
S003 1988-05-17 Normal 180 Day Track
S002 1986-08-19 Normal 180 Day Track
S001 1986-06-17 Special (immediate Track)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.